Skip to main content

Day: May 7, 2025

INSPIRA ART100 System Approved by Israel’s Largest Healthcare Provider for Use in Organ Transplant Patients

RA’ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been approved by Israel’s largest healthcare provider to undergo a clinical validation by leading physicians who intend to use the innovative life-support and diagnostic device during organ transplant procedures.  As part of this advancement, Inspira will deploy the U.S. Food and Drug Administration (“FDA”) approved INSPIRA ART100 system at one of Israel’s renowned medical centers affiliated with the largest health care provider. A team of pioneering physicians at a renowned medical center has requested to validate the INSPIRA ART100 system...

Continue reading

Lendlease Global Commercial REIT’s Singapore Portfolio Achieves Positive Retail Rental Reversion and Office Rental Uplift in 3Q FY2025

Key HighlightsRetail portfolio achieved a positive rental reversion of 10.4%1 with tenant retention rate remained healthy at 87.9%2 by net lettable area (“NLA”). Jem office achieved a positive rental uplift of approximately 13%3. Visitation registered a decline of 0.2%4 and tenant sales declined 5.1%4 (both year-to-date), impacted by a softer retail landscape, outbound tourism and weakness in specific trade sectors like shoes & bags, fashion & accessories, and sporting goods & apparel. Refinanced S$200 million perpetual securities due in April 2025 with new issuance at a lower coupon rate and loans at lower costs of funding. Signed Shaw Theatres as a new tenant at Jem, replacing Cathay Cineplex. Completed asset enhancement works at the ground floor lobby of Building 3 in Milan, transforming it into a refreshed and welcoming...

Continue reading

Prosafe SE: Invitation to Q1 2025 Results and Webcast on May 21st

07 May 2025 – Prosafe SE will release its first quarter 2025 results on 21 May 2025. The Q1 presentation will be available on both www.newsweb.no and Prosafe’s website, www.prosafe.com. Terje Askvig, CEO, and Reese McNeel, CFO, will present the results at Pareto Securities, located at Dronning Mauds gate 3, 0115 Oslo, on 21 May 2025 at 10:00 CEST. This presentation is open to the public and will be live-streamed on Prosafe’s website.It will be possible to ask questions during the presentation by using the Q&A tool embedded in the webcast. These questions will be answered after the presentation. A replay of the audiocast will be made available on Prosafe’s website shortly after.Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For...

Continue reading

Asset Entities to Merge with Strive Asset Management to Form the First Publicly Traded Asset Management Bitcoin Treasury Company

The combined company will focus over time on maximizing Bitcoin exposure per share and seek to outperform Bitcoin over the long run and maximize value for common equity shareholders. More information provided about Strive Asset Management’s business at Strive.com. Strive CEO Matt Cole to present transaction and company strategy at Strategy World conference today at 2:15 pm ET (livestream). DALLAS, May 07, 2025 (GLOBE NEWSWIRE) — Asset Entities Inc. (“Asset Entities” or the “Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services, today announced that it has entered into a definitive merger agreement with Strive Asset Management. The combined company will operate under the Strive brand, remain listed on NASDAQ, and become a public Bitcoin Treasury Company. Strive Asset Management intends to use all...

Continue reading

Conduent Reports First Quarter 2025 Financial Results

Key Q1 2025 HighlightsRevenue and Adj. Revenue(1): $751M Pre-tax Income (Loss): $(56)M Adj. EBITDA Margin(1): 4.9% New Business Signings ACV(2): $109M Net ARR Activity Metric(2) (TTM): $116MFLORHAM PARK, N.J., May 07, 2025 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions and services company, today announced its first quarter 2025 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Conduent had a good start to 2025, especially amidst the broad uncertainty in the macro-economic landscape. Our results are in line with internal expectations and consistent with our 2025 outlook with respect to Adjusted Revenue, and Adjusted EBITDA margins exceeded expectations. New business signings and our Net ARR Activity Metric, both signals of future...

Continue reading

One Stop Systems Reports Q1 2025 Results

First quarter of 2025 consolidated gross margin increased 320 basis points year-over-year to 32.6%, on consolidated revenue of $12.3 million OSS segment gross margin of 45.5%, on OSS segment revenue of $5.2 million OSS segment experienced strong first-quarter bookings of $10.4 million Management continues to expect double-digit consolidated revenue growth in 2025 and consolidated EBITDA break even for the year ESCONDIDO, Calif., May 07, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML), autonomy and sensor processing at the edge, reported results for the three-month period ended March 31, 2025. Comparisons for the three-month periods are to the same year-ago periods unless...

Continue reading

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

– Application represents milestone toward broadening patient access to inFoods IBS – inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company and its CLIA laboratory partner have submitted an application to the American Medical Association (AMA) CPT Editorial Panel requesting the assignment of a Proprietary Laboratory Analysis (PLA) code for the inFoods® IBS diagnostic test. If granted, the PLA code will provide a test-specific code to submit claims to Medicare and other insurers. The PLA code would represent a next step on the pathway to expand...

Continue reading

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

ATH434 Phase 2 Data to be Presented at Opening Plenary Session MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster presentations related to Alterity’s clinical programs in Multiple System Atrophy (MSA) will be featured at the 2025 International MSA Congress taking place May 9 – 11, 2025 in Boston, MA, USA. The Congress is presented by Mission MSA, a non-profit organization dedicated to improving the quality of life and building hope for people affected by MSA through support services, educational resources, research funding, and community engagement. David Stamler, M.D., Chief...

Continue reading

STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update

HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2025 financial results on Wednesday, May 14, 2025 after the market close. STRATA management will subsequently host a conference call at 5:00 p.m. ET on Wednesday, May 14, 2025 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. To listen to the conference call, interested parties within the U.S. should dial 1-866-524-3160 (domestic) or 1-412-317-6760 (international). All callers should dial in approximately 10 minutes...

Continue reading

Greystone Housing Impact Investors Reports First Quarter 2025 Financial Results

OMAHA, Neb., May 07, 2025 (GLOBE NEWSWIRE) — On May 7, 2025, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended March 31, 2025. Financial Highlights The Partnership reported the following results as of and for the three months ended March 31, 2025:Net income of $0.11 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $0.31 per BUC Total assets of $1.54 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $1.18 billionThe difference between reported net income per BUC and CAD per BUC is primarily due to the treatment of unrealized losses on the Partnership’s interest rate derivative positions. Unrealized losses of approximately $3.9 million are included in net...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.